Is a complete CPIX research report available?

No complete published report is available for Cumberland Pharmaceuticals Inc. (CPIX) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Cumberland Pharmaceuticals Inc. (CPIX)

NASDAQ: CPIX · USD

$6.99

-0.13 (-1.8%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-24 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first CPIX analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	104.7M
Revenue (ttm)	41.9M
Net income (ttm)	-7.4M
EPS (ttm)	-$0.50
Shares out	15M
Volume	418,986
Beta	0.10

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 41.9M
Net income (ttm): -7.4M
EPS (ttm): -$0.50
Market cap: 104.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All CPIX indicators

Market & fundamental data

Available fields

226

Groups with data

Currency

USD

Showing 226 of 226 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001087294
Company name	Cumberland Pharmaceuticals Inc.
Country	United States
Country code	US
Cusip	230770109
Employees	93
Employees Change	2%
Employees Change Percent	2.2
Enterprise value	$103.7M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	126.2
Industry PE Fwd	14.08
IPO Date	2009-08-11
Isin	US2307701092
Last refreshed	2026-07-24
Market cap	$104.7M
Market cap category	Micro-Cap
Price	$6.99
Price currency	USD
Rev Per Employee	450,964.44x
Sector	Healthcare
Sector PE	44.59
Sector PE Fwd	23.48
Sic	2834
Symbol	CPIX
Website	https://www.cumberlandpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-7.05%
EV/FCF	75.67x
EV/Sales	2.47x
FCF yield	1.31%
P/B ratio	4.84x
P/S ratio	2.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-17.2%
EBITDA Margin	-6.73%
FCF margin	3.27%
Gross margin	82.89%
Gross Profit	$34.8M
Gross Profit Growth	0.34%
Gross Profit Growth Q	-30.04%
Gross Profit Growth3 Y	2.9%
Gross Profit Growth5 Y	2.85%
Net Income	$-7.4M
Net Income Growth Years	1%
Pretax Margin	-17.55%
Profit Margin	-17.6%
Profit Per Employee	$-79,385
ROA	-6.4
Roa5y	-4.23
ROCE	-19.76
ROE	-29.81
Roe5y	-16.67
ROIC	-33.05
Roic5y	-18.41

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	4.11%
Cagr15y	0.64%
Cagr1y	105.54%
Cagr3y	65.16%
Cagr5y	16.18%
EPS Growth Years	1
FCF Growth	-74.38%
FCF Growth Q	-89.95%
FCF Growth3 Y	-41.94%
FCF Growth5 Y	-25.99%
OCF Growth	-73.8%
OCF Growth Q	-90.07%
OCF Growth10 Y	-10.77%
OCF Growth3 Y	-41.74%
OCF Growth5 Y	-25.79%
Revenue Growth	2.09x
Revenue Growth Q	-22.04x
Revenue Growth Years	1x
Revenue Growth3 Y	1.54x
Revenue Growth5 Y	1.13x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.6
Assets	$71M
Cash	$11M
Current Assets	$32.8M
Current Liabilities	$34.5M
Debt	$10.1M
Debt Equity	$0.47
Debt FCF	$7.35
Equity	$21.3M
Interest Coverage	-17.26
Liabilities	$49.7M
Long Term Assets	$38.2M
Long Term Liabilities	$15.2M
Net Cash	$937,458
Net Cash By Market Cap	$0.9
Net Cash Growth	-79.92%
Net Debt Equity	$-0.04
Net Debt FCF	$-0.68
Tangible Book Value	$7.9M
Tangible Book Value Per Share	$0.53
WACC	4.64

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.95
Inventory Turnover	1.5
Net Working Capital	$-12.2M
Quick ratio	0.73
Working Capital	$-1.7M
Working Capital Turnover	$18

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.12%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	49.57%
1Y total return	105.44%
200-day SMA	4.11
3Y total return	350.65%
50-day SMA	6.07
50-day SMA vs 200-day SMA	50over200
5Y total return	111.67%
All Time High	17.75
All Time High Change	-60.65%
All Time High Date	2009-08-11
All Time Low	1.04
All Time Low Change	571.63%
All Time Low Date	2024-11-25
ATR	0.71
Beta	0.1
Beta1y	0.99
Beta2y	-0.04
Ch YTD	75.5
High	7.05
High52	8.09
High52 Date	2026-07-16
High52ch	-13.66%
Low	5.75
Low52	1.85
Low52 Date	2025-11-18
Low52ch	277.57%
Ma50ch	15.13%
Premarket Change Percent	-3.87
Premarket Price	$6.84
Premarket Volume	6,201
Price vs 200-day SMA	70.03%
RSI	54.17
RSI Monthly	67.16
RSI Weekly	66.56
Sharpe ratio	1.21x
Sortino ratio	2.03
Total Return	-4.12%
Tr YTD	75.5
Tr15y	10%
Tr1m	25.4%
Tr1w	-8.81%
Tr3m	129.02%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-7.2M
Operating margin	-17.2

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	8,750,192%
Float Percent	58.4%
Shares Insiders	41.6%
Shares Institutions	18.75%
Shares Out	14,983,107
Shares Qo Q	0.02%
Shares Yo Y	4.12%
Short Float	2.77%
Short Ratio	4.7
Short Shares	1.62

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$929,807
Average Volume	115,669.1x
Bv Per Share	1.44
CAPEX	$-50,273
Ch10y	49.57
Ch15y	10
Ch1m	25.4
Ch1w	-8.81
Ch1y	105.4
Ch3m	129
Ch3y	350.6
Ch5y	111.7
Ch6m	72.9
Change	-1.83%
Change From Open	3.64
Close	7.12
Days Gap	-5.34
Depreciation Amortization	4,389,900
Dollar Volume	2,926,617.2
Earnings Date	2026-08-04
Earnings Time	amc
EBIT	$-7.2M
EBITDA	$-2.8M
EPS	$-0.5
F Score	3
FCF	$1.4M
FCF EV Yield	1.32x
FCF Per Share	$0.09
Financing CF	-1,982,714
Fiscal Year End	December
Founded	1,999
Goodwill	914,000
Income Tax	$38,457
Investing CF	-3,539,484
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-09
Ma150	4.58
Ma150ch	52.58%
Ma20	6.76
Ma20ch	3.27%
Net CF	-4,101,168
Next Earnings Date	2026-08-04
Open	6.74
Optionable	Yes
P FCF Ratio	76.35
P OCF Ratio	73.65
Position In Range	95
Post Close	6.99
Postmarket Change Percent	-1.93
Postmarket Price	$6.85
Ppne	7,856,095
Pre Close	7.12
Price Date	2026-07-23
Ptbv Ratio	13.2
Relative Volume	3.62x
Revenue	41,939,693x
SBC By Revenue	1.05x
Share Based Comp	440,950
Tax By Revenue	0.09x
Tr6m	72.9%
Us State	Tennessee
Volume	418,986
Z Score	0.3

Cumberland Pharmaceuticals Inc. (CPIX)

Coverage state: Market snapshot only — no published research

Generate the first CPIX analysis

Price

Financial snapshot

Fair-value bridge

Latest news · CPIX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CPIX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on CPIX

Frequently asked questions